# Drug Use Investigation for Cervarix®

> **NCT01187927** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1230 (actual)

## Conditions studied

- Infections, Papillomavirus

## Interventions

- **BIOLOGICAL:** Cervarix®

## Key facts

- **NCT ID:** NCT01187927
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 1230 (ACTUAL)
- **Last updated:** 2015-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187927, "Drug Use Investigation for Cervarix®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01187927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*